NHLBI Catalyze R33: Validate Enabling Technologies & Platforms for HLBS Research (No Clinical Trials)
This R33 NOFO from the NHLBI Catalyze program funds mid-stage (TRL 3–4) development and rigorous validation of transformative, multi-use enabling technologies or platforms that broadly advance heart, lung, blood, and sleep (HLBS) research. Applications must have supportive preliminary data showing feasibility (first-generation prototypes), focus on platform capabilities rather than single-dise…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers